Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I trial of OMS-527

Trial Profile

A phase I trial of OMS-527

Phase of Trial: Phase I

Latest Information Update: 17 Jul 2018

At a glance

  • Drugs OMS 527 (Primary)
  • Indications Drug abuse; Obsessive-compulsive disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 17 Jul 2018 Status changed from planning to recruiting, as reported in the Omeros Corporation media release.
    • 17 Jul 2018 According to an Omeros Corporation media release, first cohort of subjects has been dosed in this clinical trial. Trial completion is expected in the first half of 2019.
    • 27 Jun 2018 Planned initiation date changed from 1 Jan 2018 to 1 Aug 2018, according to an Omeros Corporation media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top